Why is Jiangsu Cowin Biotech Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of -24.72% and Operating profit at -200.29% over the last 5 years
2
With a growth in Net Sales of 68.47%, the company declared Very Positive results in Sep 25
- DEBTORS TURNOVER RATIO(HY) Highest at 2.38 times
- RAW MATERIAL COST(Y) Fallen by -49.25% (YoY)
- INVENTORY TURNOVER RATIO(HY) Highest at 2.28 times
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -5.60%, its profits have fallen by -32.3%
4
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -5.60% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in each of the last 3 annual periods
How much should you hold?
- Overall Portfolio exposure to Jiangsu Cowin Biotech Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Jiangsu Cowin Biotech Co., Ltd. for you?
High Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Jiangsu Cowin Biotech Co., Ltd.
3.16%
0.64
42.16%
China Shanghai Composite
15.45%
1.58
14.20%
Quality key factors
Factor
Value
Sales Growth (5y)
-24.72%
EBIT Growth (5y)
-200.29%
EBIT to Interest (avg)
-37.60
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.44
Sales to Capital Employed (avg)
0.11
Tax Ratio
3.06%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
14.10%
ROE (avg)
2.89%
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.13
EV to EBIT
-10.81
EV to EBITDA
-14.09
EV to Capital Employed
4.36
EV to Sales
14.36
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-40.34%
ROE (Latest)
-12.32%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Technical Movement
22What is working for the Company
DEBTORS TURNOVER RATIO(HY)
Highest at 2.38 times
RAW MATERIAL COST(Y)
Fallen by -49.25% (YoY
INVENTORY TURNOVER RATIO(HY)
Highest at 2.28 times
NET SALES(Q)
Highest at CNY 52.46 MM
PRE-TAX PROFIT(Q)
Highest at CNY -22.96 MM
NET PROFIT(Q)
Highest at CNY -21.96 MM
EPS(Q)
Highest at CNY -0.18
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Here's what is working for Jiangsu Cowin Biotech Co., Ltd.
Net Sales
At CNY 52.46 MM has Grown at 68.47%
Year on Year (YoY)MOJO Watch
Near term sales trend is very positive
Net Sales (CNY MM)
Debtors Turnover Ratio
Highest at 2.38 times and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Net Sales
Highest at CNY 52.46 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (CNY MM)
Pre-Tax Profit
Highest at CNY -22.96 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (CNY MM)
Pre-Tax Profit
At CNY -22.96 MM has Grown at 52.81%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (CNY MM)
Net Profit
Highest at CNY -21.96 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (CNY MM)
Net Profit
At CNY -21.96 MM has Grown at 53.34%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is positive
Net Profit (CNY MM)
EPS
Highest at CNY -0.18
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (CNY)
Inventory Turnover Ratio
Highest at 2.28 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Raw Material Cost
Fallen by -49.25% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales






